Search Within

Peter Maslak

  1. "Department of Medicine"
Formats
  1. Meeting Abstract (96)
  2. Journal Article (90)
  3. Book Section (9)
  4. Conference Paper (2)
Groups
  1. Adult Leukemia (197)
  2. Center for Hematologic Malignancies (197)
  3. Department of Medicine (197)
  4. Hematologic Malignancies, Division of (197)
  5. GSK Faculty (100)
  6. Sloan Kettering Institute Faculty (85)

More Groups

People
  1. David Scheinberg (64)
  2. Joseph Jurcic (44)
  3. Mark Weiss (39)
  4. Renier Brentjens (20)
  5. Mark Heaney (19)
  6. Nicole Lamanna (18)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (5)
  4. 2020 (3)
  5. 2019 (4)
  6. 2018 (6)

More Years

Publications
  1. Blood (70)
  2. Journal of Clinical Oncology (20)
  3. Leukemia (9)
  4. Clinical Cancer Research (7)
  5. Cytotherapy (5)
  6. Transfusion (5)

More Publications

Publishers
  1. American Society of Hematology (71)
  2. American Society of Clinical Oncology (20)
  3. Nature Publishing Group (19)
  4. American Association for Cancer Research (12)
  5. Elsevier Inc. (8)
  6. Wiley Blackwell (7)

More Publishers

Results (197)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NCCN Practice Guidelines for acute myelogenous leukemia
    Journal Article

    O'Donnell, M. R.; Appelbaum, F. R.; Baer, M. R.; Carabasi, M. H.; Coutre, S. E.; Erba, H. P.; Estey, E.; Glenn, M. J.; Kraut, E. H.; Maslak, P.; more...
    Oncology (Norwalk) (2000)

    Fulltext@MSK | Save
  • Targeted therapies for the myeloid leukaemias
    Journal Article

    Maslak, P.; Scheinberg, D.
    Expert Opinion on Investigational Drugs (2000)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    Journal Article

    Weiss, M. A.; Glenn, M.; Maslak, P.; Rahman, Z.; Noy, A.; Zelenetz, A.; Scheinberg, D. A.; Golde, D. W.
    Leukemia (2000)

    Fulltext@MSK | Save
  • A phase I study of pentostatin and cyclophosphamide (CTX) for previously treated patients with CLL
    Meeting Abstract

    Weiss, M.; Maslak, P.; Scheinberg, D.; Kossman, S.
    Blood (1999)

    Fulltext@MSK | Save
  • Complete remission after clinically induced differentiation and apoptosis in acute promyelocytic leukemia by arsenic trioxide
    Meeting Abstract

    Soignet, S. L.; Maslak, P.; Chen, Y. W.; Calleja, E.; Pandolfi, P. P.; Scheinberg, D. A.; Warrell, R. P.
    British Journal of Haematology (1998)

    Fulltext@MSK | Save
  • Dose-ranging study of arsenic trioxide in advanced hematologic cancers: Clinical pharmacokinetic and biological effects
    Meeting Abstract

    Soignet, S.; Wang, Z. G.; Nagy, J.; Maslak, P.; Chanel, S.; Ho, R.; Spriggs, D.; Ellison, R.; Pandolfi, P. P.; Warrell, R. P.
    Blood (1998)

    Fulltext@MSK | Save
  • High dose idarubicin (HIda) with high dose cytarabine (HiDac) as induction therapy for newly diagnosed patients with AML
    Meeting Abstract

    Maslak, P.; Weiss, M.; Jurcic, J.; Jimenez, J.; Berman, E.; Golde, D.; Scheinberg, D.
    Blood (1998)

    Fulltext@MSK | Save
  • Long term survival in patients with acute myelogenous leukemia (AML) and favorable prognosis cytogenetic abnormalities
    Meeting Abstract

    Kossman, S. E.; Maslak, P. G.; Weiss, M. A.; Berman, E.; Jhanwar, S.; Scheinberg, D. A.
    Blood (1998)

    Fulltext@MSK | Save
  • Western study of arsenic trioxide (As(2)O(3)) in patients with relapsed and/or refractory acute promyelocytic leukemia
    Meeting Abstract

    Soignet, S. L.; Maslak, P.; Chen, Y. W.; Calleja, E.; Pandolfi, P. P.; Scheinberg, D. A.; Warrell, R. P. Jr
    Annals of Oncology (1998)

    Fulltext@MSK | Save
  • The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia
    Journal Article

    Maslak, P.; Nimer, S. D.
    Seminars in Hematology (1998)

    Fulltext@MSK | Save